This is a full-throated and compelling defense of double-blinded, randomized, controlled trials even - and especially - in resource-constrained situations with

This is a full-throated and compelling defense of double-blinded, randomized, controlled trials even - and especially - in resource-constrained situations with a terrible disease like Ebola. It is far more interesting and historical than the title suggests, and if you have not yet done so I encourage you to read the article.